Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study

被引:11
|
作者
Kumar, Kanta [1 ,2 ]
Peters, Sarah [3 ]
Barton, Anne [2 ,4 ]
机构
[1] Univ Manchester, Sch Hlth Sci, Manchester M13 9PL, Lancs, England
[2] Univ Manchester, Arthrit Res UK Ctr Genet & Genom, Ctr Musculoskeletal Res, Inst Inflammat & Repair, Manchester M13 9PL, Lancs, England
[3] Manchester Ctr Hlth Psychol, Sch Hlth Sci, Manchester M13 9PL, Lancs, England
[4] Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal BRU, Manchester, Lancs, England
关键词
Rheumatoid arthritis; Predictive testing; Patient perspective; PSYCHOLOGICAL IMPACT; SOCIETY; TRIAL; RISK;
D O I
10.1186/s12891-016-1319-x
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Rheumatoid arthritis (RA) is a long term condition that requires early treatment to control symptoms and improve long-term outcomes. Lack of response to RA treatments is not only a waste of healthcare resources, but also causes disability and distress to patients. Identifying biomarkers predictive of treatment response offers an opportunity to improve clinical decisions about which treatment to recommend in patients and could ultimately lead to better patient outcomes. The aim of this study was to explore the understanding of and factors affecting Rheumatoid Arthritis (RA) patients' decisions around predictive treatment testing. Methods: A qualitative study was conducted with a purposive sample of 16 patients with RA from three major UK cities. Four focus groups explored patient perceptions of the use of biomarker tests to predict response to treatments. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis by three researchers. Results: Data were organised within three interlinking themes: [1] Perceptions of predictive tests and patient preference of tests; [2] Utility of the test to manage expectations; [3] The influence of the disease duration on take up of predictive testing. During consultations for predictive testing, patients felt they would need, first, careful explanations detailing the consequences of untreated RA and delayed treatment response and, second, support to balance the risks of tests, which might be invasive and/or only moderately accurate, with the potential benefits of better management of symptoms. Conclusions: This study provides important insights into predictive testing. Besides supporting clinical decision making, the development of predictive testing in RA is largely supported by patients. Developing strategies which communicate risk information about predictive testing effectively while reducing the psychological burden associated with this information will be essential to maximise uptake.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [1] Rheumatoid arthritis patient perceptions on the value of predictive testing for treatments: a qualitative study
    Kanta Kumar
    Sarah Peters
    Anne Barton
    BMC Musculoskeletal Disorders, 17
  • [2] PERCEPTIONS OF PATIENTS WITH RHEUMATOID ARTHRITIS ABOUT PREDICTIVE TESTING FOR TREATMENTS: A QUALITATIVE STUDY
    Kumar, K.
    Cordingley, L.
    Maskell, D.
    Nair, N.
    Barton, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1304 - 1304
  • [3] QUALITATIVE STUDY OF PUBLIC PERCEPTIONS OF PREDICTIVE GENETIC TESTING FOR RHEUMATOID ARTHRITIS
    Wells, Imogen
    Simons, Gwenda
    Woehlke, Sabine
    Schicktanz, Silke
    Hansson, Mats
    Raza, Karim
    Falahee, Marie
    RHEUMATOLOGY, 2019, 58 : 186 - 186
  • [4] Diagnostic and predictive value of laboratory testing in rheumatoid arthritis
    Musset, L.
    Ghillani-Dalbin, P.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2013, 28 (5-6): : 281 - 286
  • [5] PATIENTS' PERCEPTIONS OF RISK, RISK COMMUNICATION AND PREDICTIVE TESTING FOR RHEUMATOID ARTHRITIS
    Falahee, M.
    Simons, G.
    Stack, R. J.
    Raza, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 200 - 200
  • [6] Perceptions of risk and predictive testing held by the first-degree relatives of patients with rheumatoid arthritis in England, Austria and Germany: a qualitative study
    Stack, Rebecca J.
    Stoffer, Michaela
    Englbrecht, Mathias
    Mosor, Erika
    Falahee, Marie
    Simons, Gwenda
    Smolen, Josef
    Schett, Georg
    Buckley, Chris D.
    Kumar, Kanta
    Hansson, Mats
    Hueber, Axel
    Stamm, Tanja
    Raza, Karim
    BMJ OPEN, 2016, 6 (06):
  • [7] Public perceptions of predictive testing for rheumatoid arthritis compared to breast cancer and early-onset Alzheimer’s disease: a qualitative study
    Juhi Singhal
    Imogen Wells
    Gwenda Simons
    Sabine Wöhlke
    Karim Raza
    Marie Falahee
    BMC Rheumatology, 6
  • [8] Public perceptions of predictive testing for rheumatoid arthritis compared to breast cancer and early-onset Alzheimer's disease: a qualitative study
    Singhal, Juhi
    Wells, Imogen
    Simons, Gwenda
    Wohlke, Sabine
    Raza, Karim
    Falahee, Marie
    BMC RHEUMATOLOGY, 2022, 6 (01)
  • [9] Patient Goals for Living with Rheumatoid Arthritis: A Qualitative Study
    Cozad, Melanie J.
    Lindley, Lisa C.
    Crosby, Kaitlyn
    Alshareef, Noor
    Kennedy, Ann Blair
    Merchant, Gulzar
    Evans, Pam
    Horner, Ronnie D.
    CLINICAL NURSING RESEARCH, 2023, 32 (01) : 40 - 48
  • [10] Patient access to rheumatoid arthritis treatments
    Joensson, Bengt
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2008, 8 (Suppl 2): : S35 - S38